Effectiveness of ayurvedic formulation, NAOQ19 along with standard care in the treatment of mild-moderate COVID-19 patients: A double blind, randomized, placebo-controlled, multicentric trial.
Bhardwaj P, Ganapathy K, Pathania M, Naveen KH, Charan J, Dutta S, Gadepalli R, Srinivasan S, Gupta MK, Goel AD, Midha N, Kumar B, Sharma M, Sharma P, Banerjee M, Mitra P, Misra S, V V, Subramaniant G, R P, Dhar M, Saxena V, Dhamija P, Singh A, Subramanian S, Kanchibhotla D.
Bhardwaj P, et al. Among authors: r p.
J Ayurveda Integr Med. 2023 Nov-Dec;14(6):100778. doi: 10.1016/j.jaim.2023.100778. Epub 2023 Nov 15.
J Ayurveda Integr Med. 2023.
PMID: 37976809
Free PMC article.
RESULT: The results demonstrated more people turning RT-PCR negative in the NAOQ19 group compared to the placebo group on day 3 (p-value = 0.033). The mean time duration to turn RT-PCR negative was significantly lower in the NAOQ19 group (4.6 days) compared to placebo grou …
RESULT: The results demonstrated more people turning RT-PCR negative in the NAOQ19 group compared to the placebo group on day 3 (p-va …